UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

AdaptHealth Corp.

(Exact name of registrant as specified in its charter)

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): November 13, 2019

 

Delaware

 

001-38399

 

82-3677704

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

220 West Germantown Pike, Suite 250

Plymouth Meeting, PA
(address of principal executive offices)

 

19462

(zip code)

 

(610) 630-6357

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communication pursuant to Rule 425 under the Securities Act (17 UR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CPR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

AHCO

 

The Nasdaq Stock Market LLC

Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50

 

AHCOW

 

The Nasdaq Stock Market LLC

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 13, 2019, AdaptHealth Corp. issued a press release announcing the financial results of its subsidiary, AdaptHealth Holdings LLC, for the three and nine months ended September 30, 2019. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)           Exhibits

 

99.1

Press Release announcing AdaptHealth Holdings LLC’s Third Quarter 2019 Financial Results

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AdaptHealth Corp.

 

 

 

 

By:

/s/ Gregg Holst

 

 

Gregg Holst

 

 

Chief Financial Officer

 

Dated: November 13, 2019

 

3

DFB Healthcare Acquisiti... (NASDAQ:DFBHU)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more DFB Healthcare Acquisiti... Charts.
DFB Healthcare Acquisiti... (NASDAQ:DFBHU)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more DFB Healthcare Acquisiti... Charts.